ITIA President asserts that there is no difference in treatment between players
Karen Moorhouse, President of the ITIA (International Tennis Integrity Agency), talks to Tennis365.
She stated that Jannik Sinner and Iga Swiatek had not received any preferential treatment compared to players like Halep.
She explains: "It's the same rules and the same processes for all players. All cases are different and each case is based on specific facts.
Cases can also be quite complex, so it doesn't make sense to look at two headlines and make comparisons between two cases, because the detail is always the key element.
Take Halep, for example. The CAS court concluded that her supplement was contaminated.
So, just on that conclusion, they handed down a nine-month suspension.
As for Swiatek, the contaminated product was a medicine.
So it wasn't unreasonable for a player to assume that a regulated drug would contain what its composition indicated.
Halep's contamination was not due to a drug. It was a collagen supplement, and her failure level turned out to be higher.
The key point here is that it's rare to find two identical cases; they all depend on particular facts."
